https://doi.org/10.1074/jbc.m116.748483
R
Rachelle W. Johnson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
3.3K
Citations
31
h-index
45
i10-index
Rachelle W. Johnson is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Bone health and treatments & Bone Metabolism and Diseases & Cancer Cells and Metastasis. The author has an h-index of 31, co-authored 80 publications.
ORCID: 0000-0003-2755-9851Papers by this author
worksMurine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass
2016 · Journal of Biological Chemistry · 55 citations
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms
2023 · Journal of bone oncology · 32 citations
https://doi.org/10.1016/j.jbo.2023.100505
Enrichment and detection of bone disseminated tumor cells in models of low tumor burden
2018 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-018-32653-2
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner
2021 · Communications Biology · 19 citations
https://doi.org/10.1038/s42003-021-02648-3
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer
2021 · Journal of bone oncology · 15 citations
https://doi.org/10.1016/j.jbo.2021.100407
PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR
2024 · Breast Cancer Research · 4 citations
https://doi.org/10.1186/s13058-024-01791-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat